Case Report
Accepted on 05 Sep 2024
Case Report: Toripalimab plus Anlotinib in Postoperative Recurrent Renal Pelvic Sarcomatoid Urothelial Carcinoma
in Genitourinary Oncology
Case Report
Accepted on 05 Sep 2024
in Genitourinary Oncology
Original Research
Accepted on 05 Sep 2024
in Geohazards and Georisks
Review
Accepted on 05 Sep 2024
in Host and Microbe Associations
Original Research
Accepted on 05 Sep 2024
in Avian Physiology
Review
Accepted on 05 Sep 2024
in Neuropharmacology
Original Research
Accepted on 05 Sep 2024
in Breast Cancer
Systematic Review
Accepted on 05 Sep 2024
in Ethnopharmacology
Original Research
Accepted on 05 Sep 2024
in Ethnopharmacology
Editorial
Accepted on 05 Sep 2024
in Neuropsychology
Conceptual Analysis
Accepted on 05 Sep 2024
in Neuropsychology
Original Research
Accepted on 05 Sep 2024
in Veterinary Infectious Diseases
Brief Research Report
Accepted on 05 Sep 2024
in T Cell Biology
Original Research
Accepted on 05 Sep 2024
in Cytokines and Soluble Mediators in Immunity
Specialty Grand Challenge
Accepted on 05 Sep 2024
in Integrative Systems Neuroscience
Editorial
Accepted on 05 Sep 2024
in Molecular and Cellular Oncology
Original Research
Accepted on 05 Sep 2024
in Hypertension